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Activated Neutrophils Exert Antitumor ActivityAgainst Human
Melanoma Cells: Reactive Oxygen Species-Induced Mechanisms
and Their Modulation by Granulocyte-Macrophage^Colony-
Stimulating Factor
To the Editor:
Rapid and marked in¢ltration of polymorphonuclear cells
(PMN) into tumors genetically modi¢ed to produce cytokines
including tumor necrosis factor-a (TNF-a) and granulocyte-
macrophage^colony-stimulating factor (GM^CSF) has been ob-
served in several preclinical cancer vaccine models (Cavallo et al,
1992; Colombo et al, 1992; Armstrong et al, 1996; Musiani et al,
1996). In some of these models, tumor rejection is the result of a
biphasic e¡ector phase consisting of a rapid in£ammatory re-
sponse mediated by PMN and subsequent development of an
adaptive immune response (Golumbek et al, 1991; Hock et al,
1993). Conversely, granulocyte depletion signi¢cantly interferes
with the development of protective antitumor responses (No¡z
et al, 1998). Pronounced in¢ltration of PMN into metastases is
also observed in melanoma patients after intratumoral injection
of a GM^CSF/vaccinia construct (Mastrangelo et al, 1999) or vac-
cination with autologous GM^CSF-transduced tumor cells (Soif-
fer et al, 1998). Conceptually, tumor cell destruction by activated
PMN may release not only dead tumor cell remnants which are
phagocytosed by dendritic cells but also proin£ammatory stimuli
such as cytokines, chemokines, or DNA fragments building up
the conditions for e⁄cient presentation of tumor antigens to T
lymphocytes (Pardoll, 2003).
Cytokines such as TNF-a or GM^CSF directly and indirectly
stimulate PMN functions including phagocytosis and degranula-
tion. During activation, PMN generate a respiratory burst that
releases reactive oxygen species (ROS) (Gougerot-Pocidalo et al,
2002). Superoxide anions (O2
^) and their dismutated descendant
hydrogen peroxide (H2O2) can interact with transition metal ions
to generate hydroxyl radicals (OH). OH as well as the other reac-
tion product of O2
^ with nitric oxide (NO), peroxynitrite
(ONOO^), can damage cellular proteins, lipids, DNA (Finkel
and Holbrook, 2000; Halliwell, 2000), and in addition to H2O2,
mitochondria with subsequent release of cytochrome c and in-
duction of target cell apoptosis (Kamat and Devasagayam, 2000;
Kannan and Jain, 2000; Herrera et al, 2001). To date, it is not clear
whether PMN contribute to melanoma rejection by regulatory
or direct tumoricidal activity. Thus, we asked whether 1) neutro-
phils can directly exert antitumoral e¡ects on melanoma cells in
vitro; 2) generation of ROS is involved in these antitumoral ef-
fects, and 3) these e¡ects are modulated by GM^CSF.
For coculture experiments, PMN were isolated from healthy
adult volunteers by venipuncture and prepared by centrifugation
(900 g, 20 min) on a discontinuous dense (3 mL of 55% and 4
mL of 74%) Percoll gradient (Sigma, Deisenhofen, Germany),
essentially as described (Walzog et al, 1997). The purity of PMN
preparations was usually 495% (morphology), with viability
498% cells (trypan blue exclusion). These freshly isolated PMN
were ‘‘primed’’ by incubation for 15 min at room temperature
with human recombinant GM^CSF or TNF-a (Sigma) at con-
centrations tested to give the best results and directly incubated
in increasing numbers with three di¡erent human melanoma cell
lines (SK-MEL-28, SK-MEL-3, and HT-144; ATCC, Rockville,
MD) grown to subcon£uency in 12-well dishes (Greiner, Solin-
gen, Germany). PMN were subsequently activated by N-formyl-
methionyl-leucyl-phenylalanine (FMLP) (Sigma) as described
(Elbim et al, 1994; Walzog et al, 1997) and cocultured with mela-
noma cells for 72 h.Whereas no signi¢cant e¡ect on target cell
viability could be detected when melanoma cells were incubated
with unprimed PMN, incubation with GM^CSF-primed and
FMLP-activated PMN induced signi¢cantly reduced melanoma
cell viability, comparable to levels obtained with control TNF-
a-primed PMN (Fig 1A). This e¡ect was clearly not cell-line-
speci¢c as comparable results could be obtained with all three
melanoma cell lines (data not shown). In titration assays with in-
creasing numbers (3106, 6106, 9106, or 12106) of GM^
CSF-primed PMN, reduction of melanoma cell viability to
61.98, 42.14, 32.23, and 18.18%, respectively, of the level of control
cells (SK-MEL-28 incubated with unprimed PMN) could be ob-
served. ROS release by PMN ultimately leads to the induction of
apoptotic cell death in target cells (Kannan and Jain, 2000;
Herrera et al, 2001). According to this view, cocultivation of
GM^CSF-primed PMNwith SK-MEL-28 melanoma cells resulted
in a signi¢cant induction of annexin V staining in SK-MEL-28
cells (Fig 1B).
To study the e¡ects of cytokines on the antitumor activity of
PMN, we measured the basic O2
^ release from PMN and its mod-
i¢cation by priming of PMN with GM^CSF.Whereas in control
assays direct e¡ects of GM-CSF and TNF-a on the O2
^ release
from PMN could not be observed, pre-treatment of PMN with
GM^CSF resulted in an approximately 150% increase of O2
^ re-
lease over control cells (Fig 2A). By reaching a p value of 0.09 in
statistical ANOVA and Tukey’s multiple group comparison after
testing, this increase closely missed, but showed a clear trend to-
ward statistical signi¢cance. These observations support the view
that priming with GM^CSF can result in a substantially en-
hanced O2
^ release from PMN.
O2
^ release results in the stepwise generation of several ROS
with OH as the most destructive oxidant. To further identify the
ROS intermediates responsible for PMN-induced reduction of
melanoma cell viability, we performed inhibition studies with
speci¢c antioxidants. O2
^ is dismutated by superoxide anion dis-
mutase (SOD) to H2O2. If H2O2 is not detoxi¢ed by catalase to
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Figure1. Cytokine (GM^CSF)-priming of PMN leads to signi¢-
cantly reduced viability of melanoma cells via induction of apopto-
sis. (A) Coculturing experiments of melanoma cells with PMN.
Melanoma cells were subjected to cytokine-primed (1 U/mL GM^CSF or
100 ng/mLTNF-a) and FMLP (1 mM) activated PMN.Viability of melano-
ma cells was determined after 72 h of coculture by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide dye reduction assay. Results given
for SK-MEL-28 melanoma cells: SK-MEL-28, melanoma cells cultured
alone; SK-MEL-28þPMN, melanoma cells cultured with unprimed
PMN; SK-MEL-28þPMNþGM^CSF/TNF-a, melanoma cells cultured
with GM^CSF-/TNF-a-primed PMN. Figures shown give mean values
and SD of results obtained in three independent experiments. po0.01;
#po0.001 compared to mock-treated cells (ANOVA with Tukey’s post-
test). (B) Induction of apoptosis in target melanoma cells. SK-MEL-28
melanoma cells exhibit a HLA-A11,25/26þ phenotype as con¢rmed by
£ow-cytometric staining with anti-HLA11 and anti-HLA-A25/26 mono-
clonal antibodies (BIH0084, BIH0048; One Lambda, Canoga Park, CA).
These SK-MEL-28 were cocultured with GM^CSF-primed PMN from
HLA-A11,25/26^ volunteers. After 72 h, SK-MEL-28 were subjected to an-
nexinV staining with the annexinV^£uorescein isothiocyanate (FITC) kit
(Immunotech, Marseille, France) and subsequent £ow-cytometry (Epics
XL, Coulter, Hialeah, FL). The rate of apoptosis of SK-MEL-28 cells was
calculated as the percentage of double-labeled annexin V^FITCþ /HLA-
A11,25/26þ cells within the HLA-A11þ,A25/26þ cell population. Con-
trols included isotype control staining with monoclonal mouse IgM-,
kIG- (clone G155-228, BD PharMingen, Heidelberg, Germany), and
camptothecin- (6 mM, Sigma) induced apoptosis in SK-MEL-28 cells. Fig-
ures shown give results obtained in an experiment representative for three
independent experiments.
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Figure 2. (A) GM^CSF-priming and superoxide anion release from
PMN. Production of O2
^ was measured as superoxide dismutase-inhibita-
ble reduction of cytochrome c (van Asbeck et al, 1984). Brie£y, PMN were
freshly isolated and primed with GM^CSF or TNF-a at concentrations
used in the previous experiments (GM^CSF at 1 U/mL, TNF-a at 100
ng/ml). PMN (1  106/ml) were carefully ¢lled in a half-microcuvette
containing PBS and 10 mM cytochrome c (Sigma). After stimulation with 1
mM FMLP, reduction of cytochrome c was measured spectrophotometri-
cally over time at 550 nm using a single-beam spectrophotometer as de-
scribed (Walzog et al, 1997). The time course of O2
^ release was calculated
from the concentration of FMLP-induced cytochrome c reduction over 1
min (Clark and Nauseef, 1998). Speci¢city of cytochrome c turnover was
con¢rmed by blocking experiments with SOD (Sigma), which immedi-
ately dismutases O2
^ to nonradical H2O2. O2
^ release of unprimed, FMLP-
activated PMN served as control and was set as 100% reference level. Pre-
treatment of PMN with GM^CSF or TNF-a resulted in a substantial in-
crease of O2
^ release over mock-treated PMN (p¼ 0.09 analyzed by ANO-
VA with Tukey’s post-test). Figures shown give mean values and SD of
results obtained in three independent experiments. (B) Inhibition of OH
generation leads to protection of melanoma cells. Incubation of SK-MEL-
28/GM^CSF-primed PMN cocultures with the OH quencher dimethyl
sulfoxide (at 1 mM) resulted in a nearly complete protection of melanoma
cells against GM^CSF-primed PMN. Antioxidants SOD or catalase alone
exhibited no signi¢cant e¡ect (p40.05), whereas combination of antioxi-
dants SOD (at 300 U/ml) and catalase (at 6250 U/ml) signi¢cantly pro-
tected melanoma cells. Note viability levels comparable to those observed
in mock-treated melanoma cells. Similarly, incubation of SK-MEL-28/
GM^CSF-primed PMN cocultures with arginine analogon (1 mM NG-
monomethyl-L-arginine) resulted in a nearly complete protection of mela-
noma cells.Viability levels observed in mock-treated melanoma cells served
as controls and were set as 100% reference level. Figures shown give results
obtained in an experiment representative for three independent experi-
ments. po0.001 compared to PMN-incubated SK-MEL-28 (ANOVA
withTukey’s post-test).
LETTERTO THE EDITOR 937VOL. 121, NO. 4 OCTOBER 2003
H2O and O2, generation of OH results. Alternatively, O2
^ is also
able to react with NO, which results in the formation of
ONOO^. In turn, ONOO^ itself can also serve as a starting
point for the stepwise generation of OH. The biological e¡ects
of OH can be blocked by its quencher dimethyl sulfoxide. Pre-
incubation of melanoma cells with dimethyl sulfoxide resulted
in signi¢cant and nearly complete inhibition of the reduction of
melanoma cell viability by GM^CSF-primed PMN (Fig 2B). In
contrast, dismutation of O2
^ with antioxidant SOD or detoxi¢ca-
tion of H2O2 by catalase alone revealed no signi¢cant protective
e¡ect. Nevertheless, simultaneous dismutation of O2
^ and detoxi-
¢cation of H2O2 by combination of SOD and catalase resulted in
signi¢cant protection (Fig 2B). An alternative pathway of ROS
generation may constitute the formation of ONOO^ by reaction
of O2
^ with NO.When indirectly blocking this pathway by inter-
fering with the generation of NO through incubation with argi-
nine analogon NG-monomethyl-L-arginine, melanoma cells were
signi¢cantly protected against GM^CSF-primed PMN (Fig 2B).
The results presented here support the assumption that cyto-
kine-primed PMN can exert direct antitumor e¡ects on melano-
ma cells and emphasize the importance of cytokine-modulated
oxidative damage of tumor cells by release of OH from PMN.
Direct antitumor activity of PMN may signi¢cantly contribute
to breaking autoimmune tolerance against tumor cells and repre-
sent an attractive target for immunotherapeutic strategies.
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